Nucleic Acids Research, 1984, Vol. 12, No. 6 2861-2878
© 1984
MOLECULAR BIOLOGY |
Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7
Laboratoire de Génétique Moléculaire des Eucaryotes du CNRS, Unité 184 de Biologie Moléculaire et de Génie Génétique de l'INSERM, Institut de Chimie Biologique, Faculté de Médecine Strasbourg, France
*To whom correspondence should be sent
Received January 30, 1984. Accepted February 17, 1984.
We present the complete sequence of an mRNA which is induced by estrogen in the human breast cancer cell line MCF-7 [pS2 mRNA, Masiakowski et al., Nucleic Acids Res. 10, 78957903 (1982)]. Primer extension and cloning of double-stranded cDNA (ds-cDNA) into a vector designed to make full-length cDNA were used to determine the sequence of the fifteen 5'-terminal nucleotides which were not present in the original pS2 ds-cDNA clone. The mRNA sequence has a major open reading frame encoding 84 amino-acids, flanked by a 40 nucleotide 5'-untranslated region and a 198 nucleotide 3'-untranslated region preceding the polyA tail. The 3'-untranslated region contains a polyadenylation signal, AUUAAA, 14 nucleotides upstream from the polyA tail. The derived protein sequence contains a putative signal peptide region suggesting that the protein may be secreted. The nucleotide and derived amino-acid sequences were compared to previously determined sequences, particularly to those of hormone-regulated proteins and growth factors, and no obvious similarities were observed.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. W. Woodfield, A. D. Horan, Y. Chen, and R. J. Weigel TFAP2C Controls Hormone Response in Breast Cancer Cells through Multiple Pathways of Estrogen Signaling Cancer Res., September 15, 2007; 67(18): 8439 - 8443. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Smyth, C. Gourley, G. Walker, M. J. MacKean, A. Stevenson, A. R.W. Williams, A. A. Nafussi, T. Rye, R. Rye, M. Stewart, et al. Antiestrogen Therapy Is Active in Selected Ovarian Cancer Cases: The Use of Letrozole in Estrogen Receptor-Positive Patients Clin. Cancer Res., June 15, 2007; 13(12): 3617 - 3622. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kuske, C. Naughton, K. Moore, K. G MacLeod, W. R Miller, R. Clarke, S. P Langdon, and D. A Cameron Endocrine therapy resistance can be associated with high estrogen receptor {alpha} (ER{alpha}) expression and reduced ER{alpha} phosphorylation in breast cancer models Endocr. Relat. Cancer, December 1, 2006; 13(4): 1121 - 1133. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Carroll and M. Brown Estrogen Receptor Target Gene: An Evolving Concept Mol. Endocrinol., August 1, 2006; 20(8): 1707 - 1714. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Oh, M. A. Troester, J. Usary, Z. Hu, X. He, C. Fan, J. Wu, L. A. Carey, and C. M. Perou Estrogen-Regulated Genes Predict Survival in Hormone Receptor-Positive Breast Cancers J. Clin. Oncol., April 10, 2006; 24(11): 1656 - 1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Vestergaard, M. Borre, S. S. Poulsen, E. Nexo, and N. Torring Plasma Levels of Trefoil Factors are Increased in Patients with Advanced Prostate Cancer Clin. Cancer Res., February 1, 2006; 12(3): 807 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-Y. Wang, R. Fulthorpe, S. N. Liss, and E. A. Edwards Identification of Estrogen-Responsive Genes by Complementary Deoxyribonucleic Acid Microarray and Characterization of a Novel Early Estrogen-Induced Gene: EEIG1 Mol. Endocrinol., February 1, 2004; 18(2): 402 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Morrison, R. E. Herrera, E. C. Heinsohn, R. Schiff, and C. K. Osborne Dominant-Negative Nuclear Receptor Corepressor Relieves Transcriptional Inhibition of Retinoic Acid Receptor but Does Not Alter the Agonist/Antagonist Activities of the Tamoxifen-Bound Estrogen Receptor Mol. Endocrinol., August 1, 2003; 17(8): 1543 - 1554. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Demirpence, A. Semlali, J. Oliva, P. Balaguer, E. Badia, M.-J. Duchesne, J.-C. Nicolas, and M. Pons An Estrogen-responsive Element-targeted Histone Deacetylase Enzyme Has an Antiestrogen Activity That Differs from That of Hydroxytamoxifen Cancer Res., November 15, 2002; 62(22): 6519 - 6528. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Vestergaard, S. S. Poulsen, H. Gronbaek, R. Larsen, A. M. Nielsen, K. Ejskjaer, J. T. Clausen, L. Thim, and E. Nexo Development and Evaluation of an ELISA for Human Trefoil Factor 3 Clin. Chem., October 1, 2002; 48(10): 1689 - 1695. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liu, W.-C. Park, D. J. Bentrem, K. P. McKian, A. D. L. Reyes, J. A. Loweth, J. M. Schafer, J. W. Zapf, and V. C. Jordan Structure-Function Relationships of the Raloxifene-Estrogen Receptor-alpha Complex for Regulating Transforming Growth Factor-alpha Expression in Breast Cancer Cells J. Biol. Chem., March 8, 2002; 277(11): 9189 - 9198. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Leffers, M. Nasby, B. Vendelbo, N. E. Skakkebak, and M. Jorgensen Oestrogenic potencies of Zeranol, oestradiol, diethylstilboestrol, Bisphenol-A and genistein: implications for exposure assessment of potential endocrine disrupters Hum. Reprod., May 1, 2001; 16(5): 1037 - 1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Havrilesky, C. P. McMahon, E. K. Lobenhofer, R. Whitaker, J. R. Marks, and A. Berchuck Relationship Between Expression of Coactivators and Corepressors of Hormone Receptors and Resistance of Ovarian Cancers to Growth Regulation by Steroid Hormones Reproductive Sciences, April 1, 2001; 8(2): 104 - 113. [Abstract] [PDF] |
||||
![]() |
T. Bouras, M. C. Southey, and D. J. Venter Overexpression of the Steroid Receptor Coactivator AIB1 in Breast Cancer Correlates with the Absence of Estrogen and Progesterone Receptors and Positivity for p53 and HER2/neu Cancer Res., February 1, 2001; 61(3): 903 - 907. [Abstract] [Full Text] |
||||
![]() |
A. H. Charpentier, A. K. Bednarek, R. L. Daniel, K. A. Hawkins, K. J. Laflin, S. Gaddis, M. C. MacLeod, and C. M. Aldaz Effects of Estrogen on Global Gene Expression: Identification of Novel Targets of Estrogen Action Cancer Res., November 1, 2000; 60(21): 5977 - 5983. [Abstract] [Full Text] |
||||
![]() |
M P A Ebert, J Hoffmann, C Haeckel, K Rutkowski, R M Schmid, M Wagner, G Adler, H U Schulz, A Roessner, W Hoffmann, et al. Induction of TFF1 gene expression in pancreas overexpressing transforming growth factor alpha Gut, July 1, 1999; 45(1): 105 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xie, R. Duan, and S. Safe Estrogen Induces Adenosine Deaminase Gene Expression in MCF-7 Human Breast Cancer Cells: Role of Estrogen Receptor-Sp1 Interactions Endocrinology, January 1, 1999; 140(1): 219 - 227. [Abstract] [Full Text] |
||||
![]() |
C. P. Tran, M. Familari, L. M. Parker, R. H. Whitehead, and A. S. Giraud Short-chain fatty acids inhibit intestinal trefoil factor gene expression in colon cancer cells Am J Physiol Gastrointest Liver Physiol, July 1, 1998; 275(1): G85 - G94. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A.C. Pratt, D. Deonarine, C. Teixeira, D. Novosad, B. F. Tate, and J. F. Grippo The AF-2 Region of the Retinoic Acid Receptor alpha Mediates Retinoic Acid Inhibition of Estrogen Receptor Function in Breast Cancer Cells J. Biol. Chem., August 23, 1996; 271(34): 20346 - 20352. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Williams, G. Stamp, C Gilbert, M Pignatelli, and E. Lalani pS2 transfection of murine adenocarcinoma cell line 410.4 enhances dispersed growth pattern in a 3-D collagen gel J. Cell Sci., January 1, 1996; 109(1): 63 - 71. [Abstract] [PDF] |
||||
![]() |
M. Rio, J. Bellocq, J. Daniel, C Tomasetto, R Lathe, M. Chenard, A Batzenschlager, and P Chambon Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa Science, August 5, 1988; 241(4866): 705 - 708. [Abstract] [PDF] |
||||













